| 126 | PSYCHOTROPIC MEDICATIONS IN MOOD DISORDERS: CURRENT ATTITUDE IN TWO PSYCHIATRIC WARDS IN CAGLIARI
1)Baggiani G. 2)Ambrosiani L. 3)Deidda A. 4)Bocchetta A. 5)Trincas P. 6)Burrai C. |
| 160 | ACTIVITY-BASED ANOREXIA ALTERS NEUROMETABOLIC MEASURES IN ADOLESCENT FEMALE RATS
1)Fumagalli F. 2)Bonacina F. 3)Messa G. 4)Uboldi P. 5)Norata GD. 6)Caffino L. |
| 166 | HYPERPROLACTINEMIA INDUCED BY ANTIPSYCHOTICS: FROM DIAGNOSIS TO TREATMENT APPROACH
1)Capasso A.. 2)Milano W.. |
| 167 | DO CANNABINOIDS CONFER NEUROPROTECTION AGAINST EPILEPSY?
1)Capasso A.. 2)Milano W.. |
| 168 | THE PSYCHOBIOLOGY OF ENDOCANNABINOIDS IN THE EATING DISORDERS
1)Capasso A.. 2)Milano W.. |
| 169 | BENEFICAL EFFECTS OF POLYPHENOLS IN NEUROINFLAMMATION AND RELATED DISEASES
1)Capasso A.. 2)Milano W.. |
| 170 | PROTECTIVE EFFECT OF HDAC INHIBITORS IN NEURODEGENERATIVE DISORDERS
1)Capasso A.. 2)Milano W.. |
| 171 | CANNABINOIDS INVOLVEMENT IN NEURODEGENERATIVE DISEASES
1)Capasso A.. 2)Milano W.. |
| 198 | THE ROLE OF SNPs ANALYSIS IN NEUROCOGNITIVE ASSESSMENT OF CHILDREN WITH CHRONIC OR SEVERE DISEASES SUCH AS EPILEPSY, ASTHMA OR ACUTE LYMPHOBLASTIC LEUKEMIA
1)Colliva C. 2)Benatti C. 3)Tascedda F. 4)Dalla Porta F. 5)Ferrari M. 6)Bergamini BM. 7)Cellini M. 8)Guerra A. 9)Blom J. |
| 200 | CANNABINOID INVOLVMENT IN THE DEVELOPMENT OF SCHIZOPHRENIA BEHAVIORAL PHENOTYPES
1)Contarini G. 2)Mereu M. 3)Papaleo F. |
| 265 | Acute behavioral and molecular effects of the cathinones MDPV and _-PVP in the mouse brain
1)Caffino L. 2)Canazza I. 3)Mottarlini F. 4)Bilel S. 5)Ossato A. 6)Giannotti G. 7)Racagni G. 8)Marti M. 9)Fumagalli F. |
| 269 | CHRONIC CANNABIDIVARIN ADMINISTRATION RESCUES AUTISM-LIKE BEHAVIORS INDUCED BY PRENATAL VALPROIC ACID EXPOSURE IN MALE OFFSPRING
1)Gabaglio M.. 2)Zamberletti E.. 3)Piscitelli F.. 4)Rubino T.. 5)Di marzo V.. 6)Parolaro D.. |
| 368 | Multiple sclerosis and depression comorbidity: deciphering the role of early-life adversities
1)Paladini MS. 2)Coppolino GT. 3)Rossetti AC. 4)Marangon D. 5)Fumagalli M. 6)Lecca D. 7)Abbracchio MP. 8)Molteni R. |
| 411 | MODELLING ANHEDONIA TO STUDY MECHANISMS OF RESILIENCE/VULNERABILITY TOWARDS ACUTE STRESS
1)Sala N. 2)Musazzi L. 3)Tornese P. 4)Seguini M. 5)Popoli M. |
| 424 | NEWER LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: AN OBSERVATIONAL COMPARATIVE STUDY OF AVAILABLE FORMULATIONS
1)Spina E.. 2)Santoro V.. 3)Bruno A.. 4)Muscatello M.. 5)Nucifora D.. 6)D'amico G.. 7)Zoccali R.. |
| 428 | INHIBITION OF 5-ALPHA REDUCTASE RESCUES PSYCHOTIC- AND MANIC-LIKE PHENOTYPES INDUCED BY SLEEP DEPRIVATION
1)Traccis F. 2)Bini V. 3)Soggiu A. 4)Scheggi S. 5)Pardu A. 6)Fanni S. 7)Roncada P. 8)Puligheddu M. 9)Marrosu F. 10)Caruso D. 11)Devoto P. 12)Frau R. 13)Bortolato M. |
| 441 | EFFECTS OF A NOVEL SELECTIVE SHORT-ACTING KAPPA OPIOID RECEPTOR ANTAGONIST ON COCAINE INTAKE DURING ESCALATION AND UPON RE-EXPOSURE AFTER WITHDRAWAL
1)Valenza M. 2)Butelman ER. 3)Kreek MJ. |
